Skip to main content
Read about

Coffee's Potential Shield Against Parkinson's: Clues Revealed in EPIC Study

Coffee's Potential Shield Against Parkinson's
On this page
Tooltip Icon.
Written by Andrew Le, MD.
Last updated June 6, 2024

Try our free symptom checker

Get a thorough self-assessment before your visit to the doctor.

In a groundbreaking study spanning six European countries, researchers have shown a positive link between regular coffee consumption and a lower risk of developing Parkinson's disease (PD). The expansive EPIC4PD (European Prospective Investigation into Cancer and Nutrition) study, published in Neurology® 2021, delved into this intriguing association by harnessing both self-reported dietary data and advanced biomarker analysis.

The study, which tracked over 184,000 individuals, found that participants who drank the most coffee had a 37% reduced risk of developing PD compared to non-coffee drinkers. What's more striking is that by examining blood samples taken before PD diagnosis, researchers identified specific caffeine metabolites, such as paraxanthine and theophylline, that showed a similar inverse relationship with PD risk.

The detailed identification and quantification of plasma caffeine and its metabolites years before diagnosis strengthen the argument for coffee's neuroprotective properties. While previous studies relied on subjective dietary questionnaires, the EPIC4PD study's use of objective blood markers offers a more reliable estimation of caffeine's effect on PD development.

While the findings must be replicated, they could open the door to potential prevention strategies, including the use of caffeine as a protective agent, particularly during the prodromal phase of PD. However, the researchers caution that advocating for increased coffee consumption or caffeine supplements requires a careful consideration of potential side effects.

For those looking for a possible way to reduce their risk of Parkinson's, this large-scale research offers a compelling argument for the inclusion of coffee in the daily routine. It's an example of science providing actionable insights in the pursuit of better health outcomes.

For a deeper dive into the full research article, access it directly at the Neurology journal website [link not provided].

Built with the help of Buoy Health.

Share your story
Once your story receives approval from our editors, it will exist on Buoy as a helpful resource for others who may experience something similar.
The stories shared below are not written by Buoy employees. Buoy does not endorse any of the information in these stories. Whenever you have questions or concerns about a medical condition, you should always contact your doctor or a healthcare provider.
Dr. Le obtained his MD from Harvard Medical School and his BA from Harvard College. Before Buoy, his research focused on glioblastoma, a deadly form of brain cancer. Outside of work, Dr. Le enjoys cooking and struggling to run up-and-down the floor in an adult basketball league.

Was this article helpful?

Tooltip Icon.

References

Zhao, Y., Lai, Y., Konijnenberg, H., Huerta, J. M., Vinagre-Aragon, A., ... & Vermeulen, R. (2024). Association of coffee consumption and prediagnostic caffeine metabolites with incident Parkinson disease in a population-based cohort. Neurology, 102(8), e209201. https://doi.org/10.1212/WNL.0000000000209201